| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |